These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 8908480)

  • 1. Immunoglobulin G response against 10-kDa and 65-kDa heat-shock proteins in leprosy patients and their household contacts.
    Rojas RE; Segal-Eiras A
    FEMS Immunol Med Microbiol; 1996 Oct; 15(4):189-98. PubMed ID: 8908480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody response to recombinant 65-kDa, 70-kDa and 18-kDa mycobacterial antigens in leprosy patients and healthy contacts in a leprosy-endemic population.
    Ilangumaran S; Shankernarayan N; Ramu G; Muthukkaruppan V
    Int J Lepr Other Mycobact Dis; 1994 Jun; 62(2):245-55. PubMed ID: 7519226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgM anti-phenolic glycolipid I and IgG anti-10-kDa heat shock protein antibodies in sera and immune complexes isolated from leprosy patients with or without erythema nodosum leprosum and contacts.
    Rojas RE; Demichelis SO; Sarno EN; Segal-Eiras A
    FEMS Immunol Med Microbiol; 1997 Sep; 19(1):65-74. PubMed ID: 9322070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serodiagnosis of leprosy: relationships between antibodies to Mycobacterium leprae phenolic glycolipid I and protein antigens.
    Levis WR; Meeker HC; Schuller-Levis GB; Gillis TP; Marino LJ; Zabriskie J
    J Clin Microbiol; 1986 Dec; 24(6):917-21. PubMed ID: 3537003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular and humoral immune responses to recombinant 65-kD antigen of Mycobacterium leprae in leprosy patients and healthy controls.
    Ilangumaran S; Shanker Narayan NP; Ramu G; Muthukkaruppan VR
    Clin Exp Immunol; 1994 Apr; 96(1):79-85. PubMed ID: 8149671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgM and IgG antibodies to phenolic glycolipid I from Mycobacterium leprae in leprosy: insight into patient monitoring, erythema nodosum leprosum, and bacillary persistence.
    Levis WR; Meeker HC; Schuller-Levis G; Sersen E; Schwerer B
    J Invest Dermatol; 1986 May; 86(5):529-34. PubMed ID: 3528312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody responses to the 18-kDa protein of Mycobacterium leprae in leprosy and tuberculosis patients.
    Roche PW; Prestidge RL; Watson JD; Britton WJ
    Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):201-7. PubMed ID: 1381739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgA antibodies against phenolic glycolipid I from Mycobacterium leprae in serum of leprosy patients and contacts: subclass distribution and relation to disease activity.
    Schwerer B; Chujor CS; Bernheimer H; Radl J; Haaijman JJ; Meeker HC; Sersen G; Levis WR
    Clin Immunol Immunopathol; 1989 Nov; 53(2 Pt 1):202-11. PubMed ID: 2676273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific anti-M leprae PGL-I antibodies and Mitsuda reaction in the management of household contacts in New Caledonia.
    Desforges S; Bobin P; Brethes B; Huerre M; Moreau JP; Bach MA
    Int J Lepr Other Mycobact Dis; 1989 Dec; 57(4):794-800. PubMed ID: 2681462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to a synthetic analog of phenolic glycolipid-I of Mycobacterium leprae in healthy household contacts of patients with leprosy.
    Menzel S; Harboe M; Bergsvik H; Brennan PJ
    Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4):617-25. PubMed ID: 3323365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to phenolic glycolipid-1 and to whole Mycobacterium leprae in leprosy patients: evolution during therapy.
    Bach MA; Wallach D; Flageul B; Hoffenbach A; Cottenot F
    Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):256-67. PubMed ID: 3522769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-reactivity of anti-10kD heat shock protein antibodies in leprosy and tuberculosis patients.
    Rojas RE; Demichelis SO; Giménez MF; Molinari ML; Segal-Eiras A
    Medicina (B Aires); 1997; 57(5):581-6. PubMed ID: 9674227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Armadillo IgG and IgM antibody responses to phenolic glycolipid-I during experimental infection with M. leprae.
    Vadiee AR; Shannon EJ; Gillis TP; Mshana RN; Hastings RC
    Int J Lepr Other Mycobact Dis; 1988 Sep; 56(3):422-7. PubMed ID: 3047283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential monitoring of leprosy patients with serum antibody levels to phenolic glycolipid-I, a synthetic analog of phenolic glycolipid-I, and mycobacterial lipoarabinomannan.
    Meeker HC; Schuller-Levis G; Fusco F; Giardina-Becket MA; Sersen E; Levis WR
    Int J Lepr Other Mycobact Dis; 1990 Sep; 58(3):503-11. PubMed ID: 2205685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgM antibodies to native phenolic glycolipid-I in contacts of leprosy patients in Venezuela: epidemiological observations and a prospective study of the risk of leprosy.
    Ulrich M; Smith PG; Sampson C; Zuniga M; Centeno M; Garcia V; Manrique X; Salgado A; Convit J
    Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):405-15. PubMed ID: 1890364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological activity of a characteristic phenolic glycolipid from Mycobacterium leprae in sera from patients with leprosy and tuberculosis.
    Brett SJ; Draper P; Payne SN; Rees RJ
    Clin Exp Immunol; 1983 May; 52(2):271-9. PubMed ID: 6407793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-PGL1 salivary IgA/IgM, serum IgG/IgM, and nasal Mycobacterium leprae DNA in individuals with household contact with leprosy.
    Brito e Cabral P; Júnior JE; de Macedo AC; Alves AR; Gonçalves TB; Brito e Cabral TC; Gondim AP; Pinto MI; Oseki KT; Camara LM; Rabenhorst SH; Nagao-Dias AT
    Int J Infect Dis; 2013 Nov; 17(11):e1005-10. PubMed ID: 23871279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serological evidence of Toxoplasma gondii infection as potential risk for the development of lepromatous leprosy in an endemic area for both neglected tropical diseases in Brazil.
    Oliveira LRP; Martins LM; Souza RDC; Scheidegger de Castro Y; Nascimento LS; da Silva JA; Nahn Junior EP; da Silva WD; Peixoto-Rangel AL
    Infect Dis Poverty; 2020 Feb; 9(1):19. PubMed ID: 32051036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serologic responses to Mycobacterium leprae-specific phenolic glycolipid-I antigen in sooty mangabey monkeys with experimental leprosy.
    Gormus BJ; Ohashi DK; Ohkawa S; Walsh GP; Meyers WM; Brennan PJ; Trygg C
    Int J Lepr Other Mycobact Dis; 1988 Dec; 56(4):537-45. PubMed ID: 2464657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of four semi-synthetic Mycobacterium leprae antigens with sera from healthy populations in endemic and non-endemic areas.
    Douglas JT; Steven LM; Hirsch DS; Fujiwara T; Nelson KE; Madarang MG; Cellona RV
    Lepr Rev; 1992 Sep; 63(3):199-210. PubMed ID: 1406016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.